Literature DB >> 9449891

Trichomonas vaginalis and amplification of HIV-1 transmission.

F Sorvillo, P Kerndt.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9449891     DOI： 10.1016/S0140-6736(05)78181-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  53 in total

1.  Predictors of infection with Trichomonas vaginalis: a prospective study of low income African-American adolescent females.

Authors:  R Crosby; R J DiClemente; G M Wingood; K Harrington; S L Davies; E W Hook; M K Oh
Journal:  Sex Transm Infect       Date:  2002-10       Impact factor: 3.519

2.  The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.

Authors:  Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger
Journal:  Sex Transm Infect       Date:  2011-01-29       Impact factor: 3.519

3.  Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions.

Authors:  F J Bowden; G P Garnett
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

4.  Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.

Authors:  T Meri; T S Jokiranta; L Suhonen; S Meri
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.

Authors:  Andrea L Crowell; Kolby A Sanders-Lewis; W Evan Secor
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

6.  Double stranded RNA virus in South African Trichomonas vaginalis isolates.

Authors:  B Weber; T M Mapeka; M A Maahlo; A A Hoosen
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

7.  Activities of dicationic compounds against Trichomonas vaginalis.

Authors:  Andrea L Crowell; Chad E Stephens; Arvind Kumar; David W Boykin; W Evan Secor
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

9.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

Review 10.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.